Omeq Medical featured in BioTuesdays
Omeq Medical revolutionizing epidural injection procedures
By Melane LaBelle Sampson, BioTuesdays
For the first time in a century, administration of epidural needles is being transformed with a smart device developed by closely-held Omeq Medical, which has completed a proof of concept (POC) preclinical study, is currently preparing for FDA submission, and expects to initiate first-in-human trials later this year.
“Our device integrates with standard syringe and needle kits to turn them into smart needles that alert physicians with visual indications once the needle penetrates into the right spot, and prevents overshooting into the spine,” Lior Margalit, co-founder and CEO, says in an interview with BioTuesdays.
It is estimated that over 40 million epidural injections are administered annually throughout the world with inaccurate initial needle placement occurring in up to 30% of those cases, resulting in ineffective drug delivery, multiple insertions, and post-complications such as severe headaches, nerve damage and paralysis, he contends.